IP Library Granted Patent US 9,044,523
Granted Patent B2
US 9,044,523 · App. 11/840,759 · Granted Jun 2, 2015

Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light

Inventors: Dennis J. Hlavinka (Arvada, CO); Raymond P. Goodrich (Lakewood, CO); Heather Reddy (Denver, CO)
Assignee: TERUMO BCT, INC.
A61L2/24A61K41/0019A61L2/0011A61L2/0088A61L2/08A61L2/10C07F11/005C07F13/005C07F15/02C07F17/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,044,523
App. No.
11/840,759
Granted
Jun 2, 2015
Kind
B2
Abstract

Methods and apparatuses are provided for reduction of pathogens in fluids containing blood products. Preferred methods include the steps of adding an effective, non-toxic amount of a photosensitizer such as riboflavin to the blood product and exposing the fluid to light having a peak wavelength.

Claims (10)

1. A method for reducing pathogens in a fluid containing red blood cells comprising:

reducing pathogens in the fluid while reducing the formation of methemoglobin in the fluid containing red blood cells and reducing hemolysis of the red blood cells by:

adding riboflavin to the fluid at a concentration of 500 μM; and

exposing the mixture of the fluid and the riboflavin to light with a wavelength of 302 nm, wherein all light except light with the wavelength of 302 nm is filtered out wherein an exposed fluid is obtained.

2. The method of claim 1 wherein the exposing step comprises exposing the mixture to pulsed light at the wavelength of 302 nm.

3. The method of claim 1 wherein the method reduces the formation of methemoglobin in the exposed fluid to less than 3%.

4. The method of claim 1 further comprising a step of storing the exposed fluid.

5. The method of claim 4 wherein the method reduces the formation of methemoglobin during storage of the exposed fluid.

6. The method of claim 1 further comprising:

mixing the fluid and riboflavin during the exposing step to expose the majority of the fluid to the light.

Assignments (5)
CHANGE OF NAME Recorded Feb 16, 2012
From: CARIDIANBCT BIOTECHNOLOGIES, LLC.
To: TERUMO BCT BIOTECHNOLOGIES, LLC
Reel/Frame 027715/0552 →
RELEASE OF SECURITY INTEREST Recorded Aug 11, 2011
From: CITICORP TRUSTEE COMPANY LIMITED, AS SECUIRTY AGENT
To: CARIDIANBCT BIOTECHNOLOGIES, LLC
Reel/Frame 026737/0537 →
IP SECURITY AGREEMENT SUPPLEMENT Recorded May 21, 2009
From: CARIDIANBCT BIOTECHNOLOGIES, LLC
To: CITICORP TRUSTEE COMPANY LIMITED
Reel/Frame 022714/0560 →
CHANGE OF NAME Recorded Jul 28, 2008
From: NAVIGANT BIOTECHNOLOGIES, LLC
To: CARIDIANBCT BIOTECHNOLOGIES, LLC.
Reel/Frame 021301/0079 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2007
From: HLAVINKA, DENNIS J.; GOODRICH, RAYMOND P.; REDDY, HEATHER L.
To: NAVIGANT BIOTECHNOLOGIES, LLC
Reel/Frame 019713/0224 →
Continuity (6)
Continuation In Part 10904361 · Nov 5, 2004
Continuation 10357599 · Feb 3, 2002
Continuation In Part 09962029 · Sep 25, 2001
Continuation In Part 09596429 · Jun 15, 2000
Provisional Application 60822726 · Aug 17, 2006
Related Publication 20080176208A1 · Jul 24, 2008